Search
Search
About
Log in
Join
Experiences with
Triple bromide
Posts
Communities
5,301 public posts
Filter results
IBS general: my experience
Dear all, it's been a while since I posted this, so here it is: This is my general approach to help people understand and repair their gastro-intestinal (GI) performance after being diagnosed with IBS. Firstly, IBS must be diagnosed by your doctor or consultant, after checks and treatment for gastro-intestinal
Dear all, it's been a while since I posted this, so here it is: This is my general approach to help people understand and repair their gastro-intestinal (GI) performance after being diagnosed with IBS. Firstly, IBS must be diagnosed by your doctor or consultant, after checks and treatment for gastro-intestinal
Stuart24
in
IBS Network
3 years ago
Weight Gain Acalabrutinib?
Hi Fellow Acalabrutinib Friends Since beginning to participate in a Acalabrutinib clinical trial several months ago, I have experienced a slow but steady increase in weight. I have cut back on calorie intake and exercised more, yet my weight continues to increase? All advice welcome. Thanks
Hi Fellow Acalabrutinib Friends Since beginning to participate in a Acalabrutinib clinical trial several months ago, I have experienced a slow but steady increase in weight. I have cut back on calorie intake and exercised more, yet my weight continues to increase? All advice welcome. Thanks
spanish36
in
CLL Support
3 years ago
Is there a better PET tracer for NSCLC than F-18?
My mom was recently diagnosed and her F-18 PET showed a 6cm tumor in her left lung. Her lower pulmonary lobe is collapsed, and the MO is thinking that the pleura might also be involved. She's afraid of having a Thoracoscopy and asked me if there is a more precise PET available. For reference sake,
My mom was recently diagnosed and her F-18 PET showed a 6cm tumor in her left lung. Her lower pulmonary lobe is collapsed, and the MO is thinking that the pleura might also be involved. She's afraid of having a Thoracoscopy and asked me if there is a more precise PET available. For reference sake,
V10fanatic
in
The Roy Castle Lung Cancer Foundation
3 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
CAR T-Cell Use Possible in Metastatic Castration-Resistant Prostate Cancer
A few years off but one to keep an eye on. CAR T-Cell Use Possible in Metastatic Castration-Resistant Prostate Cancer March 7, 2022 Nichole Tucker In an interview with Targeted Oncology, Tanya Dorff, MD, discussed the exploration of chimeric antigen receptor T-cell therapy in prostate cancer, including
A few years off but one to keep an eye on. CAR T-Cell Use Possible in Metastatic Castration-Resistant Prostate Cancer March 7, 2022 Nichole Tucker In an interview with Targeted Oncology, Tanya Dorff, MD, discussed the exploration of chimeric antigen receptor T-cell therapy in prostate cancer, including
Scout4answers
in
Advanced Prostate Cancer
3 years ago
68Ga-PSMA-11 PET/CT scan again. I forgot the prerequisites for qualifying.
It has been a long two and a half years since my first 68Ga-PSMA-11 PET Scan. That one i was a part of a clinical trial @ IU School of Medicine Urology. Status: I've been on only 250mg of Abiraterone daily, prednisone 5mg and stopped Lupron Depot injects last June 2021. August 2019 PSA 14.393...
It has been a long two and a half years since my first 68Ga-PSMA-11 PET Scan. That one i was a part of a clinical trial @ IU School of Medicine Urology. Status: I've been on only 250mg of Abiraterone daily, prednisone 5mg and stopped Lupron Depot injects last June 2021. August 2019 PSA 14.393...
depotdoug
in
Advanced Prostate Cancer
3 years ago
Combination T4/t3 therapy discussed
I can't remember if I've already posted this, but if not here the paper is - available,
Current Medical Research and Opinion
Volume 37, 2021 - Issue 12
Endocrinology
Triiodothyronine alongside levothyroxine in the management of hypothyroidism?
Ulrike Gottwald-Hostalek
I can't remember if I've already posted this, but if not here the paper is - available,
Current Medical Research and Opinion
Volume 37, 2021 - Issue 12
Endocrinology
Triiodothyronine alongside levothyroxine in the management of hypothyroidism?
Ulrike Gottwald-Hostalek
diogenes
in
Thyroid UK
3 years ago
ERSO follow up
Hi my wonderful mbc worriers and fighters, I decided to reach out to the Systems Oncology CEO. This is the company that works on development of ErSo Dfp. They keep updating us saying that more and more time is needed for its development. At the same time, researchers that developed the original compound
Hi my wonderful mbc worriers and fighters, I decided to reach out to the Systems Oncology CEO. This is the company that works on development of ErSo Dfp. They keep updating us saying that more and more time is needed for its development. At the same time, researchers that developed the original compound
Cureforever
in
SHARE Metastatic Breast Cancer
3 years ago
Anyone know of any Clinical Trials offering Lu177 (hormone sensitive) no prior chemo?
Thank you
Thank you
Longterm101
in
Advanced Prostate Cancer
3 years ago
How to Increase BDNF
So somebody over on FB posted they were taking BDNF for PD anxiety (or maybe just for anxiety) so I Googled and found BDNF = Brain-Derived Neurotrophic Factor and BDNF supplements do not contain Brain-Derived Neurotrophic Factor. But I did find this article on strongcoffee.com. https://strongcoffeecompany.com
So somebody over on FB posted they were taking BDNF for PD anxiety (or maybe just for anxiety) so I Googled and found BDNF = Brain-Derived Neurotrophic Factor and BDNF supplements do not contain Brain-Derived Neurotrophic Factor. But I did find this article on strongcoffee.com. https://strongcoffeecompany.com
Bolt_Upright
in
Cure Parkinson's
3 years ago
Digestome Therapeutics announces that the first patient has been enrolled in a Phase 1 clinical trial investigating DGX-001
Digestome Therapeutics announces that the first patient has been enrolled in a Phase 1 clinical trial investigating DGX-001 - an oral, vagus nerve stimulating therapeutic targeting non-motor symptoms in patients with #Parkinsons Digestome Therapeutics Announces First Patient Enrolled in Phase 1 Clinical
Digestome Therapeutics announces that the first patient has been enrolled in a Phase 1 clinical trial investigating DGX-001 - an oral, vagus nerve stimulating therapeutic targeting non-motor symptoms in patients with #Parkinsons Digestome Therapeutics Announces First Patient Enrolled in Phase 1 Clinical
Hidden
in
Cure Parkinson's
3 years ago
Webinar re. MPN Clinical Trials as an Option
Should you consider an MPN clinical trial? In this webinar, Dr. Ruben Mesa will provide an overview of clinical trials—including the phases—and define common trial terms and types. Dr. Mesa will also share advice for trial participation and give an update on the latest advances in MPN research. Dr
Should you consider an MPN clinical trial? In this webinar, Dr. Ruben Mesa will provide an overview of clinical trials—including the phases—and define common trial terms and types. Dr. Mesa will also share advice for trial participation and give an update on the latest advances in MPN research. Dr
hunter5582
in
MPN Voice
3 years ago
My Jevtana/Carboplatin results to date. Plus participation in Bipolar Androgen Therapy testing
This is from my previous post which is much more detailed if you’re interested. I’ll pick up where that left off. [“Jan 2022 PSA was 497.55 Alkaline Phosphatase was 92 after 4 infusions of Cabazataxcel. After seeing the results of my last CT scan done on Jan. 2022, my Oncologists told me she had
This is from my previous post which is much more detailed if you’re interested. I’ll pick up where that left off. [“Jan 2022 PSA was 497.55 Alkaline Phosphatase was 92 after 4 infusions of Cabazataxcel. After seeing the results of my last CT scan done on Jan. 2022, my Oncologists told me she had
Mount_Rainier
in
Advanced Prostate Cancer
3 years ago
Presentation by Dr. Jonathan Sackner-Bernstein: "What If I Discovered the Silver Bullet?" (rescheduled)
I am delighted to announce that this rescheduled zoom session will be taking place at 7.30 pm London time on Monday, the 28th of March. We will be using a Zoom Webinar format instead of a Zoom Meeting to avoid the problems that we had last time. This will be seamless for our participants. Dr. Jonathan
I am delighted to announce that this rescheduled zoom session will be taking place at 7.30 pm London time on Monday, the 28th of March. We will be using a Zoom Webinar format instead of a Zoom Meeting to avoid the problems that we had last time. This will be seamless for our participants. Dr. Jonathan
Michel0220
in
Cure Parkinson's
3 years ago
FDA Approves New Combination Treatment Using Immunotherapy Before Surgery for Early-Stage NSCLC
On March 4th, 2022, the Food and Drug Administration (FDA) approved Opdivo (nivolumab) for treatment before surgery in combination with platinum-based chemotherapy in patients with stage IB to IIIA non-small cell lung cancer (NSCLC). The approval was based on the results of the clinical trial CHECKMATE
On March 4th, 2022, the Food and Drug Administration (FDA) approved Opdivo (nivolumab) for treatment before surgery in combination with platinum-based chemotherapy in patients with stage IB to IIIA non-small cell lung cancer (NSCLC). The approval was based on the results of the clinical trial CHECKMATE
Miranda_GO2
Partner
in
Lung Cancer Support
3 years ago
Link to all Parkinson’s clinical trials
I came across the following website that lists all Parkinson‘s clinical trials. I am sharing this for those of you who are interested. https://neuinfo.org/data/source/nlx_154697-5/search?q=%22Parkinson+disease%22&l=%22Parkinson+disease%22
I came across the following website that lists all Parkinson‘s clinical trials. I am sharing this for those of you who are interested. https://neuinfo.org/data/source/nlx_154697-5/search?q=%22Parkinson+disease%22&l=%22Parkinson+disease%22
Michel0220
in
Cure Parkinson's
3 years ago
Proteus
Good morning Did anyone participate in the proteus clinical trial. Thanks
Good morning Did anyone participate in the proteus clinical trial. Thanks
Johnko
in
Advanced Prostate Cancer
3 years ago
What is AMX0035, and Why Is It Important for All of Us?
AMX0035 is a drug combination of sodium phenylbutyrate (PB) and tauroursodeoxycholic acid (TUDCA). It works by regulating the mitochondrial (cell power supply) and endoplasmic reticulum (quality control centers). Put simply, both processes should work in unison, but when they don’t, cells in the body
AMX0035 is a drug combination of sodium phenylbutyrate (PB) and tauroursodeoxycholic acid (TUDCA). It works by regulating the mitochondrial (cell power supply) and endoplasmic reticulum (quality control centers). Put simply, both processes should work in unison, but when they don’t, cells in the body
SilentEchoes
in
Cure Parkinson's
3 years ago
Ferroptosis is a hot topic for Parkinsons research in 2022
New opinion piece reviews the association between iron deposition, glial activation, & neuronal death, explores how ferroptosis affects α-synuclein aggregation, & reviews clinical trials https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(22)00044-2 https://twitter.com/ScienceofPD/status
New opinion piece reviews the association between iron deposition, glial activation, & neuronal death, explores how ferroptosis affects α-synuclein aggregation, & reviews clinical trials https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(22)00044-2 https://twitter.com/ScienceofPD/status
Hidden
in
Cure Parkinson's
3 years ago
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
Highlights
• Oral NR increases brain NAD levels in individuals with Parkinson’s disease • NR intake alters cerebral metabolism in Parkinson’s disease • Cerebral NAD increase is associated with clinical improvement in Parkinson’s disease • NR induces transcription of mitochondrial, lysosomal, and
Highlights
• Oral NR increases brain NAD levels in individuals with Parkinson’s disease • NR intake alters cerebral metabolism in Parkinson’s disease • Cerebral NAD increase is associated with clinical improvement in Parkinson’s disease • NR induces transcription of mitochondrial, lysosomal, and
Hidden
in
Cure Parkinson's
3 years ago
Reduced risk of Alzheimers disease in 15,820 people with T2D randomized to GLP-1R agonists in clinical trials and in Danish registry
Reduced risk of incident #Alzheimers disease in 15,820 people with #T2D randomized to GLP-1R agonists in clinical trials and in Danish registry data https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12268
Reduced risk of incident #Alzheimers disease in 15,820 people with #T2D randomized to GLP-1R agonists in clinical trials and in Danish registry data https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12268
Hidden
in
Cure Parkinson's
3 years ago
1
...
65
66
67
...
100
Next page
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1326 results
Cure Parkinson's
664 results
CLL Support
633 results
View top 10 communities
Sort by
Most Relevant
Newest